摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(3-hydroxypropionyl)-1,2,3,4-tetrahydro-5H-<1>benzopyrano<4,3-c>pyridine | 81402-28-0

中文名称
——
中文别名
——
英文名称
5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(3-hydroxypropionyl)-1,2,3,4-tetrahydro-5H-<1>benzopyrano<4,3-c>pyridine
英文别名
5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(3-hydroxypropionyl)-1,2,3,4-tetrahydro-5H-[1]benzopyrano[4,3-c]pyridine;3-hydroxy-1-[10-hydroxy-5,5-dimethyl-8-(3-methyloctan-2-yl)-3,4-dihydro-1H-chromeno[4,3-c]pyridin-2-yl]propan-1-one
5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(3-hydroxypropionyl)-1,2,3,4-tetrahydro-5H-<1>benzopyrano<4,3-c>pyridine化学式
CAS
81402-28-0
化学式
C26H39NO4
mdl
——
分子量
429.6
InChiKey
WSVBYUINVGIAJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    70
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-(3-hydroxypropionyl)-1,2,3,4-tetrahydro-5H-<1>benzopyrano<4,3-c>pyridine溴乙酰溴三乙胺吗啉 在 ice 、 氮气氢氧化钾 、 precipitate 、 二氯甲烷 、 residue 、 乙二醇二甲醚 作用下, 以 二氯甲烷 为溶剂, 反应 23.5h, 以to give 2.76 g of the above-titled compound, m.p. 217°-219° C.的产率得到5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-2-morpholinoacetyl-2,3,4,4a-tetrahydro-5H-[1]-benzopyrano[4,3-c]pyridine
    参考文献:
    名称:
    2,8-Disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and
    摘要:
    本发明提供了式I-III所表示的2,8-二取代-10-羟基-5,5-二甲基-四氢和六氢-5H-[1]-苯并吡喃[4,3-c]吡啶:其中:R选择自由基,包括C.sub.4-C.sub.20直链或支链烷基、C.sub.8-14C.sub.20直链或支链芳基烷基;n是1-4之间的整数;X是OH、NR.sub.1R.sub.2,其中R.sub.1和R.sub.2是相同或不同的氢和低烷基的成员,以及##STR2##其中Y是CH.sub.2、S、O或NR.sub.1;以及其药学上可接受的盐。这些化合物可用作降压剂。
    公开号:
    US04305938A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    New antihypertensive cannabinoids
    摘要:
    A number of azacannabinoids containing hydroxyacyl and aminoacetyl substituents on the nitrogen atom were synthesized. The hydroxyacetyl and gamma-hydroxybutyryl derivatives were potent antihypertensive agents (minimum effective dose, 3-5 mg/kg, orally) of the same order of activity as the highly CNS-active N-propargyl derivatives Ia and Ib. Furthermore, 4a showed weak stimulant properties at hypotensive dose levels, in contrast to the strongly CNS-depressant action characteristic of the N-propargyl analogues.
    DOI:
    10.1021/jm00356a017
点击查看最新优质反应信息

文献信息

  • US4305938A
    申请人:——
    公开号:US4305938A
    公开(公告)日:1981-12-15
  • New antihypertensive cannabinoids
    作者:Harold E. Zaugg、Jaroslav Kyncl
    DOI:10.1021/jm00356a017
    日期:1983.2
    A number of azacannabinoids containing hydroxyacyl and aminoacetyl substituents on the nitrogen atom were synthesized. The hydroxyacetyl and gamma-hydroxybutyryl derivatives were potent antihypertensive agents (minimum effective dose, 3-5 mg/kg, orally) of the same order of activity as the highly CNS-active N-propargyl derivatives Ia and Ib. Furthermore, 4a showed weak stimulant properties at hypotensive dose levels, in contrast to the strongly CNS-depressant action characteristic of the N-propargyl analogues.
  • 2,8-Disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and
    申请人:Abbott Laboratories
    公开号:US04305938A1
    公开(公告)日:1981-12-15
    The present invention provides 2,8-disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and hexahydro-5H-[1]-benzopyrano[4,3-c]pyridines represented by Formulae I-III: ##STR1## wherein: R is selected from the group consisting of C.sub.4 -C.sub.20 straight or branched chain alkyl, C.sub.8 14 C.sub.20 straight or branched chain arylalkyl; n is an integer from 1-4 inclusive; and X is OH, NR.sub.1 R.sub.2, R.sub.1 and R.sub.2 being the same or different members of the group consisting of hydrogen and loweralkyl, and ##STR2## wherein Y is CH.sub.2, S, O or NR.sub.1 ; and the pharmaceutically acceptable salts thereof. The compounds are useful as antihypertensive agents.
    本发明提供了式I-III所表示的2,8-二取代-10-羟基-5,5-二甲基-四氢和六氢-5H-[1]-苯并吡喃[4,3-c]吡啶:其中:R选择自由基,包括C.sub.4-C.sub.20直链或支链烷基、C.sub.8-14C.sub.20直链或支链芳基烷基;n是1-4之间的整数;X是OH、NR.sub.1R.sub.2,其中R.sub.1和R.sub.2是相同或不同的氢和低烷基的成员,以及##STR2##其中Y是CH.sub.2、S、O或NR.sub.1;以及其药学上可接受的盐。这些化合物可用作降压剂。
查看更多